VRCA
Verrica Pharmaceuticals Inc
NASDAQ: VRCA · HEALTHCARE · BIOTECHNOLOGY
$6.37
-3.19% today
Updated 2026-04-30
Market cap
$112.18M
P/E ratio
—
P/S ratio
3.15x
EPS (TTM)
$-1.68
Dividend yield
—
52W range
$3 – $10
Volume
0.1M
Verrica Pharmaceuticals Inc (VRCA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $12.00M | $12.00M | $9.03M | $5.12M | $7.57M | $35.58M |
| Revenue growth (YoY) | — | — | — | — | — | +0.0% | -24.7% | -43.3% | +47.7% | +370.2% |
| Cost of revenue | $0.00 | $0.00 | $20294.00 | $257199.00 | $229000.00 | $472000.00 | $725000.00 | $746000.00 | $2.74M | $3.44M |
| Gross profit | $0.00 | $0.00 | $-20294.00 | $-257199.00 | $-229000.00 | $11.53M | $8.31M | $4.38M | $4.83M | $32.14M |
| Gross margin | — | — | — | — | -1.9% | 96.1% | 92.0% | 85.4% | 63.8% | 90.3% |
| R&D | $1.71M | $3.73M | $12.83M | $15.44M | $15.67M | $15.93M | $12.20M | $20.30M | $11.84M | $8.86M |
| SG&A | $204000.00 | $727000.00 | $9.05M | $14.64M | $24.51M | $26.98M | $17.41M | $47.30M | $58.02M | $35.22M |
| Operating income | $-1.91M | $-4.46M | $-21.88M | $-30.08M | $-40.18M | $-30.91M | $-21.30M | $-65.76M | $-65.92M | $-11.94M |
| Operating margin | — | — | — | — | -334.8% | -257.6% | -235.8% | -1283.4% | -871.3% | -33.6% |
| EBITDA | $-1.91M | $-4.46M | $-20.63M | $-29.82M | $-39.43M | $-30.31M | $-21.60M | $-62.20M | $-65.90M | $-11.16M |
| EBITDA margin | — | — | — | — | -328.6% | -252.6% | -239.1% | -1213.8% | -871.0% | -31.4% |
| EBIT | $-1.91M | $-4.46M | $-20.65M | $-30.08M | $-39.66M | $-30.79M | $-22.32M | $-63.03M | $-67.17M | $-11.94M |
| Interest expense | $0.00 | $2000.00 | $0.00 | $0.00 | $3.03M | $4.29M | $2.17M | $3.96M | $9.41M | $7.74M |
| Income tax | $-1.91M | $-4.46M | $1.23M | $-257000.00 | $2.80M | $3.82M | $3.19M | $668105.00 | — | — |
| Effective tax rate | 50.0% | 50.0% | -6.3% | 0.9% | -6.6% | -12.2% | -15.0% | -1.0% | 0.0% | 0.0% |
| Net income | $-1.91M | $-4.46M | $-20.65M | $-27.95M | $-45.50M | $-35.08M | $-24.49M | $-67.00M | $-76.58M | $-17.89M |
| Net income growth (YoY) | — | -133.1% | -363.1% | -35.4% | -62.8% | +22.9% | +30.2% | -173.6% | -14.3% | +76.6% |
| Profit margin | — | — | — | — | -379.1% | -292.3% | -271.1% | -1307.5% | -1012.1% | -50.3% |